As­traZeneca and Dai­ichi Sankyo con­tin­ue to flesh out En­her­tu plans, claim­ing win in ear­li­er breast can­cer line

As­traZeneca and Dai­ichi Sankyo have big plans for their block­buster-in-the-mak­ing En­her­tu, and the pair tout­ed an­oth­er win Mon­day morn­ing in the quest to con­quer the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER